Literature DB >> 19557295

GAD65-Specific Cytotoxic T Lymphocytes Mediate Beta-Cell Death and Loss of Function.

Sarah Rasche1, Rhea Y Busick, Anthony Quinn.   

Abstract

Autoimmunity to islet cell antigens like glutamic acid decarboxylase 65kD (GAD65) is associated with the destruction of insulin-producing beta-cells and progression to type 1 diabetes (T1D) in NOD mice and humans. T cell responses to GAD65 are detectable in the spleen of prediabetic NOD mice and in the peripheral blood of humans prior to the onset of overt hyperglycemia. Previous findings from our lab revealed that GAD65(546-554)-specific cytotoxic T lymphocytes (CTL) are present in naïve NOD mice and are able to induce islet inflammation upon adoptive transfer into NOD.scid recipients. Additionally, we found that professional antigen-presenting cells (APC) generate the p546-554 epitope from a soluble GAD65 fragment, p530-554, and from GAD65 released by injured beta-cells in vivo. Here, we report that the GAD65 fragment p546-554 is a dominant CTL-inducing epitope which is naturally processed and presented by a GAD65-expressing beta-cell line. Further, co-culture of GAD65(546-554)-specific CTL with the beta-cells leads to a reduction in insulin production and the induction of perforin-mediated cell death. Collectively, these findings support a role for the cross-presentation of GAD65 antigen in the priming and enhancement of dominant GAD65-specific CTL responses, which can directly target beta-cells that display GAD65 epitopes.

Entities:  

Year:  2009        PMID: 19557295      PMCID: PMC2712917          DOI: 10.1900/RDS.2009.6.43

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN: 1613-6071


  38 in total

Review 1.  The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD.

Authors:  T L Delovitch; B Singh
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

2.  Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent.

Authors:  D V Serreze; H D Chapman; D S Varnum; I Gerling; E H Leiter; L D Shultz
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

3.  Identification of immunogenic epitopes of GAD 65 presented by Ag7 in non-obese diabetic mice.

Authors:  C C Chao; H O McDevitt
Journal:  Immunogenetics       Date:  1997       Impact factor: 2.846

4.  GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice.

Authors:  D Zekzer; F S Wong; O Ayalon; I Millet; M Altieri; S Shintani; M Solimena; R S Sherwin
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

5.  Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.

Authors:  R Tisch; X D Yang; S M Singer; R S Liblau; L Fugger; H O McDevitt
Journal:  Nature       Date:  1993-11-04       Impact factor: 49.962

6.  Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes.

Authors:  L S Wicker; E H Leiter; J A Todd; R J Renjilian; E Peterson; P A Fischer; P L Podolin; M Zijlstra; R Jaenisch; L B Peterson
Journal:  Diabetes       Date:  1994-03       Impact factor: 9.461

7.  Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant.

Authors:  D V Serreze; E H Leiter; G J Christianson; D Greiner; D C Roopenian
Journal:  Diabetes       Date:  1994-03       Impact factor: 9.461

8.  Localization and quantitation of expression of two glutamate decarboxylase genes in pancreatic beta-cells and other peripheral tissues of mouse and rat.

Authors:  B E Faulkner-Jones; D S Cram; J Kun; L C Harrison
Journal:  Endocrinology       Date:  1993-12       Impact factor: 4.736

9.  Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry.

Authors:  M S Horwitz; L M Bradley; J Harbertson; T Krahl; J Lee; N Sarvetnick
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

10.  CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells.

Authors:  F S Wong; I Visintin; L Wen; R A Flavell; C A Janeway
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  3 in total

1.  Development of a Bioconjugate Platform for Modifying the Immune Response of Autoreactive Cytotoxic T Lymphocytes Involved in Type 1 Diabetes.

Authors:  Neha Nandedkar-Kulkarni; Abhishek R Vartak; Steven J Sucheck; Katherine A Wall; Anthony Quinn; Michael P Morran; Marcia F McInerney
Journal:  Bioconjug Chem       Date:  2019-07-05       Impact factor: 4.774

2.  T-Cell Receptor/HLA Humanized Mice Reveal Reduced Tolerance and Increased Immunogenicity of Posttranslationally Modified GAD65 Epitope.

Authors:  Yi Jing; Yuelin Kong; John McGinty; Gabriele Blahnik-Fagan; Thomas Lee; Stephanie Orozco-Figueroa; Matthew L Bettini; Eddie A James; Maria Bettini
Journal:  Diabetes       Date:  2022-05-01       Impact factor: 9.461

Review 3.  Advances in the cellular immunological pathogenesis of type 1 diabetes.

Authors:  Min Li; Lu-Jun Song; Xin-Yu Qin
Journal:  J Cell Mol Med       Date:  2014-03-14       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.